Improved myocardial blood flow estimation with residual activity correction and motion correction in 18F-flurpiridaz

Yuka Otaki1, Serge D Van Kriekinge1, Chih-Chun Wei1

  • 1Department of Medicine (Division of Artificial Intelligence)- Imaging- and Biomedical Sciences- Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.

Abstract

Insights

Quantification of myocardial blood flow (MBF) and myocardial flow reserve (MFR) using 18F-flurpiridaz PET with motion correction (MC) and residual activity correction (RAC) significantly improves diagnostic performance for coronary artery disease (CAD). Minimal segment analysis offers superior accuracy over global assessment.

Area of Science:

  • Nuclear cardiology
  • Cardiovascular imaging
  • Radiopharmaceutical diagnostics

Background:

  • Coronary artery disease (CAD) diagnosis relies on accurate assessment of myocardial perfusion.
  • 18F-flurpiridaz positron emission tomography (PET) offers potential for quantitative myocardial blood flow (MBF) and myocardial flow reserve (MFR) assessment.
  • Image correction techniques are crucial for optimizing diagnostic accuracy in PET imaging.

Purpose of the Study:

  • To evaluate the diagnostic performance of 18F-flurpiridaz PET-derived MBF and MFR for detecting coronary artery disease (CAD).
  • To assess the impact of motion correction (MC) and residual activity correction (RAC) on diagnostic accuracy.
  • To compare the performance of global, territorial (vessel), and segmental MBF/MFR estimations.

Main Methods:

  • Utilized data from 231 patients in the Phase III Flurpiridaz trial undergoing rest/stress 18F-flurpiridaz PET.
  • Applied frame-by-frame MC and RAC by subtracting rest counts from stress polar maps.
  • Calculated MBF and MFR using a two-compartment kinetic model for global, territorial, and segmental analyses, with and without MC/RAC.

Main Results:

  • The area under the receiver operating characteristic curve (AUC) for stress MBF with MC/RAC was highest for minimal segment estimation (0.89) compared to minimal vessel (0.86) and global (0.81) assessments.
  • Similarly, the AUC for MFR with MC/RAC was highest for minimal segment (0.87) versus minimal vessel (0.83) and global (0.77) estimations.
  • MC/RAC significantly improved AUCs for minimal segment MBF and MFR compared to analyses without these corrections.

Conclusions:

  • Minimal segment MBF and MFR quantification with MC and RAC enhances diagnostic performance for obstructive CAD.
  • Segmental analysis provides superior diagnostic accuracy compared to global assessment in 18F-flurpiridaz PET imaging.
  • MC and RAC are essential for optimizing the diagnostic utility of 18F-flurpiridaz PET in CAD detection.